Herold Advisors, Inc. Amgen Inc Transaction History

Herold Advisors, Inc.

$443 Million
Q4 2024

A detailed history of Herold Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Herold Advisors, Inc. holds 5,001 shares of AMGN stock, worth $1.58 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

5,001

Previous 5,297 5.59%

Holding current value

$1.58 Million

Previous $1.71 Million 23.62%

% of portfolio

0.29%

Previous 0.38%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$258.78 - $328.31 $76,598 - $97,179	-296 Reduced 5.59%	5,001 $1.3 Million
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $2,165 - $2,361	-7 Reduced 0.13%	5,297 $1.71 Million
Q2 2024 Jul 24, 2024	BUY	$262.75 - $319.31 $103,260 - $125,488	393 Added 8.0%	5,304 $1.66 Million
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $816,558 - $985,688	3,037 Added 162.06%	4,911 $1.4 Million
Q4 2023 Feb 02, 2024	SELL	$255.7 - $288.46 $51,140 - $57,691	-200 Reduced 9.64%	1,874 $539,000
Q3 2023 Nov 08, 2023	BUY	$218.65 - $271.46 $154,585 - $191,922	707 Added 51.72%	2,074 $557,000
Q2 2023 Jul 14, 2023	BUY	$214.27 - $253.37 $59,352 - $70,183	277 Added 25.41%	1,367 $303,000
Q1 2023 Apr 19, 2023	BUY	$225.79 - $275.2 $72,252 - $88,064	320 Added 41.56%	1,090 $263,000
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $176,353 - $224,077	770 New	770 $202,000
Q2 2022 Jul 15, 2022	SELL	$230.71 - $256.74 $169,110 - $188,190	-733 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $160,724 - $177,803	733 New	733 $177,000
Q4 2021 Jan 20, 2022	SELL	$198.88 - $227.6 $145,580 - $166,603	-732 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$212.27 - $248.7 $155,381 - $182,048	732 New	732 $155,000

Others Institutions Holding AMGN

# of Institutions

3,183

Shares Held

419M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Herold Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Herold Advisors, Inc. with notifications on news.

Account

Herold Advisors, Inc. Amgen Inc Transaction History